文献速递冠心病外科

胃网膜右动脉与胸廓内动脉右支复合桥血管的10年通畅率与长期结局比较

Right gastroepiploic artery versus right internal thoracic artery composite grafts: 10-year patency and long-term outcomes.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-06-23

本研究比较了胃网膜右动脉(RGEA)与胸廓内动脉右支(RITA)复合桥血管的10年闭塞率和长期临床结局。

要点

  • 15年生存率、心脏死亡率无生存率及主要心脑血管不良事件率两组均无显著差异。

核心结论

  • 使用RGEA复合桥血管进行全动脉化再血管化的10年闭塞率和长期临床结局与使用RITA复合桥血管相当。

研究设计与样本

  • 回顾性队列研究,纳入2000年至2008年548例多支冠状动脉病变行全动脉化再血管化患者,其中RGEA组389例,RITA组159例。
  • 采用倾向性评分匹配,RGEA组与RITA组各匹配152例,比较10年血管造影闭塞率和长期临床结局。
  • 匹配后304例患者随访数据完整(100%),中位随访143.7个月。

主要发现

  • 匹配组早期临床结局相似。

临床怎么用

  • 在多支冠状动脉病变行全动脉化再血管化时,RGEA复合桥血管可作为RITA复合桥血管的替代选择,两者10年通畅率和长期临床结局相当。

局限性

  • 本研究为单中心回顾性研究,样本量有限,可能存在选择偏倚。
  • 随访时间最长15年,但部分临床结局事件数较少,统计效能可能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We compared the 10-year graft occlusion rates and long-term clinical outcomes of right gastroepiploic artery (RGEA) composite grafts with those of right internal thoracic artery (RITA) composite grafts. METHODS: From 2000 to 2008, 548 patients had undergone total arterial revascularization for multivessel coronary artery disease using the RGEA (RGEA group; n = 389) or RITA (RITA group; n = 159) as a second-limb Y-composite graft based on the in situ left ITA. A propensity score-matched analysis was used to match the RGEA group (n = 152) with the RITA group (n = 152). The 10-year angiographic occlusion rates and long-term clinical outcomes were compared. The follow-up data were complete for all 304 patients (100%) with a median follow-up of 143.7 months. RESULTS: The early clinical outcomes were similar between the matched groups. The overall graft occlusion rate was 9.5% at 10 years in the matched group patients (matched RGEA and RITA groups, 10.3% and 8.4%, respectively; P = .639). The 10-year occlusion rates of the second-limb conduits showed no differences between the matched RGEA and RITA groups (14.1% and 10.2%, respectively; P = .487). No statistically significant differences were found at 15 years postoperatively in the overall survival (52.9% vs 49.4%; P = .470), cardiac mortality-free survival (92.1% vs 90.9%; P = .560), freedom from target vessel revascularization (83.0% vs 91.4%; P = .230), freedom from reintervention (68.8% vs 76.2%; P = .731), or freedom from major adverse cardiac and cerebrovascular events (56.4% vs 64.6%; P = .364) rates between the matched groups. CONCLUSIONS: Total arterial revascularization using RGEA composite grafts showed comparable results to those using RITA composite grafts in terms of the 10-year occlusion rates and long-term clinical outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kim MS, Hwang HY, Cho KR, et al. Right gastroepiploic artery versus right internal thoracic artery composite grafts: 10-year patency and long-term outcomes. J Thorac Cardiovasc Surg. 2020. PMID: 32739170. doi:10.1016/j.jtcvs.2020.05.096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。